10-93681549-A-C
Variant summary
Our verdict is Likely benign. The variant received -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_145246.5(FRA10AC1):c.718T>G(p.Cys240Gly) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000209 in 1,575,678 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 16/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_145246.5 missense
Scores
Clinical Significance
Conservation
Publications
- neurodevelopmental disorder with growth retardation, dysmorphic facies, and corpus callosum abnormalitiesInheritance: AR Classification: STRONG, MODERATE Submitted by: G2P, Ambry Genetics
Genome browser will be placed here
ACMG classification
Our verdict: Likely_benign. The variant received -2 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0000197 AC: 3AN: 152094Hom.: 0 Cov.: 32 show subpopulations
GnomAD2 exomes AF: 0.0000274 AC: 6AN: 218996 AF XY: 0.0000336 show subpopulations
GnomAD4 exome AF: 0.0000211 AC: 30AN: 1423584Hom.: 0 Cov.: 27 AF XY: 0.0000226 AC XY: 16AN XY: 708260 show subpopulations
GnomAD4 genome AF: 0.0000197 AC: 3AN: 152094Hom.: 0 Cov.: 32 AF XY: 0.0000404 AC XY: 3AN XY: 74298 show subpopulations
ClinVar
Submissions by phenotype
Inborn genetic diseases Uncertain:1
The c.718T>G (p.C240G) alteration is located in exon 11 (coding exon 10) of the FRA10AC1 gene. This alteration results from a T to G substitution at nucleotide position 718, causing the cysteine (C) at amino acid position 240 to be replaced by a glycine (G). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at